Cargando…
Vogt–Koyanagi–Harada is a Curable Autoimmune Disease: Early Diagnosis and Immediate Dual Steroidal and Non-Steroidal Immunosuppression are Crucial Prerequisites
PURPOSE: It is crucial to subdivide Vogt–Koyanagi–Harada (VKH) disease into two subentities, initial-onset disease versus chronically evolving disease. For early diagnosis and precise follow-up of VKH choroiditis, the “Revised criteria for VKH” are no more sufficient for the appraisal of VKH and new...
Autores principales: | Papasavvas, Ioannis, Tugal-Tutkun, Ilknur, Herbort, Carl P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861101/ https://www.ncbi.nlm.nih.gov/pubmed/33553831 http://dx.doi.org/10.4103/JOCO.JOCO_190_20 |
Ejemplares similares
-
Reappraisal of the management of Vogt–Koyanagi–Harada disease: sunset glow fundus is no more a fatality
por: Herbort Jr, Carl P., et al.
Publicado: (2016) -
Indocyanine Green Angiography Guided Management of Vogt-Koyanagi-Harada Disease
por: Bouchenaki, Nadia, et al.
Publicado: (2011) -
Vogt-Koyanagi-Harada disease is always bilateral: reports of unilateral cases failed to use choroidal investigations showing subclinical involvement of the fellow eye
por: Papasavvas, Ioannis, et al.
Publicado: (2021) -
Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination
por: Papasavvas, Ioannis, et al.
Publicado: (2021) -
Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020)